Worked for the United Nations Industrial Development Organization (UNIDO) as Lead Consultant on the UNIDO – African Union Commission (AUC) partnership; and was tasked with developing a strategic plan or “business plan” for ‘operationalising’ the Pharmaceutical Manufacturing Plan for Africa (PMPA). I authored the PMPA Inception report that detailed the work to be done and the approach for developing the PMPA business plan. I co-authored the PMPA Strategic / ‘business plan’ which was adopted by the Conference of African Ministers of Health (CAMH) and endorsed by the African heads of State and Government

In my role with UNIDO, I traveled extensively around the continent, and have had consultations with stakeholders in a number of African countries, as well as with various international organizations and experts. These stakeholders, include national medicine regulators; government officials from ministries of trade / industry and health. Specifically, I interacted with government officials responsible for pharmaceutical policy and planning, industrial policy; procurement officials and government central medical stores or tender boards; investment promotion agencies; institutions of research and higher learning, pharmaceutical trade associations and individual pharmaceutical manufacturers.

In pursuance of this work, I was exposed to among others, a wide array of the pharmaceutical policy systems, data sets, multilateral organizational policies and priorities; and have developed a nuanced understanding of pharmaceutical policy frameworks and key developments in the pharmaceutical industry on the continent.



Skhumbuzo has worked on a number of assignments with international specialist research groups and has assisted their various clients decipher multiple issues around the African pharmaceutical market, including market size and competitive landscape, pricing, ARV API pricing trends, developments in the ARV treatment space evaluating the feasibility of pharmaceutical production in a number of African countries among others. He recently completed an assignment with an international investor interested in setting up a manufacturing facility in one of the fast growing African countries.


We aspire to be the first port of call for local and global bio-pharmaceutical companies and other organizations with a desire to explore and/or enter the African pharmaceutical market, to attain leadership position in the African pharmaceutical consulting space, to be known for innovation, superior service and unparalleled/exceptional project delivery capabilities.


Our mission in captured in 3 short words:

Conceive. Connect. Commit

We exist to assist global and local operating in or intent on entering the African pharma market and to conceive best in class interventions, connect with the market place and form strategic, sustainable and mutually beneficial relationships; and to commit to offer the highest quality service.


Our core values are:

  • Integrity
  • Innovation
  • Respect
  • Service excellence